Company intelligence
iBio, Inc.
AI-Powered Precision Antibody Therapeutics
Biotechnology Research
San Diego, US
58 employees
Founded 2008
1 public signals
About iBio, Inc.
iBio is a cutting-edge biotech company leveraging AI and advanced computational biology to develop next-generation biopharmaceuticals for cardiometabolic and cardiopulmonary diseases, obesity, cancer and other hard-to-treat diseases. By combining proprietary 3D modeling with innovative drug discovery platforms, iBio is creating a pipeline of breakthrough antibody treatments to address significant unmet medical needs. iBio’s mission is to transform drug discovery, accelerate development timelines, and unlock new possibilities in precision medicine.
Verified activity
Signals from iBio, Inc.
1 published signal